Literature DB >> 30429254

Combination of Nonstructural Protein 1-Based Enzyme-Linked Immunosorbent Assays Can Detect and Distinguish Various Dengue Virus and Zika Virus Infections.

Jasmine Tyson1, Wen-Yang Tsai1, Jih-Jin Tsai2,3,4,5, Carlos Brites6, Ludvig Mässgård7, Han Ha Youn1, Celia Pedroso6, Jan Felix Drexler8,9, Susan L Stramer10, Angel Balmaseda11, Eva Harris12, Wei-Kung Wang13.   

Abstract

The recent outbreaks of Zika virus (ZIKV) and associated birth defects in regions of dengue virus (DENV) endemicity emphasize the need for sensitive and specific serodiagnostic tests. We reported previously that enzyme-linked immunosorbent assays (ELISAs) based on the nonstructural protein 1 (NS1) of DENV serotype 1 (DENV1) and ZIKV can distinguish primary DENV1, secondary DENV, and ZIKV infections. Whether ELISAs based on NS1 proteins of other DENV serotypes can discriminate various DENV and ZIKV infections remains unknown. We herein developed DENV2, DENV3, and DENV4 NS1 IgG ELISAs to test convalescent- and postconvalescent-phase samples from reverse transcription-PCR-confirmed cases, including 25 primary DENV1, 24 primary DENV2, 10 primary DENV3, 67 secondary DENV, 36 primary West Nile virus, 38 primary ZIKV, and 35 ZIKV with previous DENV infections as well as 55 flavivirus-naive samples. Each ELISA detected primary DENV infection with a sensitivity of 100% for the same serotype and 23.8% to 100% for different serotypes. IgG ELISA using a mixture of DENV1-4 NS1 proteins detected different primary and secondary DENV infections with a sensitivity of 95.6% and specificity of 89.5%. The ZIKV NS1 IgG ELISA detected ZIKV infection with a sensitivity of 100% and specificity of 82.9%. On the basis of the relative optical density ratio, the combination of DENV1-4 and ZIKV NS1 IgG ELISAs distinguished ZIKV with previous DENV and secondary DENV infections with a sensitivity of 91.7% to 94.1% and specificity of 87.0% to 95.0%. These findings have important applications to serodiagnosis, serosurveillance, and monitoring of both DENV and ZIKV infections in regions of endemicity.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Zika virus; dengue virus; nonstructural protein 1; serodiagnosis

Year:  2019        PMID: 30429254      PMCID: PMC6355536          DOI: 10.1128/JCM.01464-18

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  49 in total

1.  Kinetics of anti-ZIKV antibodies after Zika infection using two commercial enzyme-linked immunoassays.

Authors:  Christophe Pasquier; Guillaume Joguet; Catherine Mengelle; Sabine Chapuy-Regaud; Lynda Pavili; Nadia Prisant; Jacques Izopet; Louis Bujan; Jean-Michel Mansuy
Journal:  Diagn Microbiol Infect Dis       Date:  2017-09-15       Impact factor: 2.803

2.  WHO recommends additional tests for Sanofi's dengue vaccine after safety concerns.

Authors:  Gareth Iacobucci
Journal:  BMJ       Date:  2018-04-20

3.  Antibody-enhanced dengue virus infection in primate leukocytes.

Authors:  S B Halstead; E J O'Rourke
Journal:  Nature       Date:  1977-02-24       Impact factor: 49.962

Review 4.  Characterizing the Pattern of Anomalies in Congenital Zika Syndrome for Pediatric Clinicians.

Authors:  Cynthia A Moore; J Erin Staples; William B Dobyns; André Pessoa; Camila V Ventura; Eduardo Borges da Fonseca; Erlane Marques Ribeiro; Liana O Ventura; Norberto Nogueira Neto; J Fernando Arena; Sonja A Rasmussen
Journal:  JAMA Pediatr       Date:  2017-03-01       Impact factor: 16.193

5.  Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections.

Authors:  D A Martin; D A Muth; T Brown; A J Johnson; N Karabatsos; J T Roehrig
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

6.  Cross reactivity of commercial anti-dengue immunoassays in patients with acute Zika virus infection.

Authors:  Alvina Clara Felix; Nathalia C Santiago Souza; Walter M Figueiredo; Angela A Costa; Marta Inenami; Rosangela M G da Silva; José Eduardo Levi; Claudio Sergio Pannuti; Camila Malta Romano
Journal:  J Med Virol       Date:  2017-03-03       Impact factor: 2.327

7.  Interim Guidance for Interpretation of Zika Virus Antibody Test Results.

Authors:  Ingrid B Rabe; J Erin Staples; Julie Villanueva; Kimberly B Hummel; Jeffrey A Johnson; Laura Rose; Susan Hills; Annemarie Wasley; Marc Fischer; Ann M Powers
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-06-03       Impact factor: 17.586

8.  Measurement of Chlamydia pneumoniae-specific immunoglobulin A (IgA) antibodies by the microimmunofluorescence (MIF) method: comparison of seven fluorescein-labeled anti-human IgA conjugates in an in-house MIF test using one commercial MIF and one enzyme immunoassay kit.

Authors:  Mika Paldanius; Aini Bloigu; Maija Leinonen; Pekka Saikku
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

9.  Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with dengue virus antibodies: a multicohort study of assay performance, 2015 to 2016.

Authors:  Katja Steinhagen; Christian Probst; Christiane Radzimski; Jonas Schmidt-Chanasit; Petra Emmerich; Marjan van Esbroeck; Janke Schinkel; Martin P Grobusch; Abraham Goorhuis; Jens M Warnecke; Erik Lattwein; Lars Komorowski; Andrea Deerberg; Sandra Saschenbrecker; Winfried Stöcker; Wolfgang Schlumberger
Journal:  Euro Surveill       Date:  2016-12-15

10.  The Nicaraguan pediatric dengue cohort study: study design, methods, use of information technology, and extension to other infectious diseases.

Authors:  Guillermina Kuan; Aubree Gordon; William Avilés; Oscar Ortega; Samantha N Hammond; Douglas Elizondo; Andrea Nuñez; Josefina Coloma; Angel Balmaseda; Eva Harris
Journal:  Am J Epidemiol       Date:  2009-05-12       Impact factor: 4.897

View more
  9 in total

1.  Evaluation of Zika rapid tests as aids for clinical diagnosis and epidemic preparedness.

Authors:  Debi Boeras; Cheikh Tidiane Diagne; Jose L Pelegrino; Marc Grandadam; Veasna Duong; Philippe Dussart; Paul Brey; Didye Ruiz; Marisa Adati; Annelies Wilder-Smith; Andrew K Falconar; Claudia M Romero; Maria Guzman; Nagwa Hasanin; Amadou Sall; Rosanna W Peeling
Journal:  EClinicalMedicine       Date:  2022-06-04

2.  Comparable Accuracies of Nonstructural Protein 1- and Envelope Protein-Based Enzyme-Linked Immunosorbent Assays in Detecting Anti-Dengue Immunoglobulin G Antibodies.

Authors:  Jedhan Ucat Galula; Gielenny M Salem; Raul V Destura; Roland Remenyi; Day-Yu Chao
Journal:  Diagnostics (Basel)       Date:  2021-04-21

3.  A high-throughput and multiplex microsphere immunoassay based on non-structural protein 1 can discriminate three flavivirus infections.

Authors:  Jasmine Tyson; Wen-Yang Tsai; Jih-Jin Tsai; Ludvig Mässgård; Susan L Stramer; Axel T Lehrer; Vivek R Nerurkar; Wei-Kung Wang
Journal:  PLoS Negl Trop Dis       Date:  2019-08-23

4.  Comparative specificity and sensitivity of NS1-based serological assays for the detection of flavivirus immune response.

Authors:  Erick Mora-Cárdenas; Chiara Aloise; Valentina Faoro; Nataša Knap Gašper; Miša Korva; Ilaria Caracciolo; Pierlanfranco D'Agaro; Tatjana Avšič-Županc; Alessandro Marcello
Journal:  PLoS Negl Trop Dis       Date:  2020-01-29

5.  The inability of a dengue NS1 ELISA to detect Zika infections.

Authors:  Monique da Rocha Queiroz Lima; Thais Chouin-Carneiro; Elzinandes Azeredo; Luciana Santos Barbosa; Thiara Manuele Alves Souza; Jéssica Badolato Corrêa da Silva; Priscila Conrado Guerra Nunes; Márcia Dal Fabbro; Izilyanne H Romanholi Facco; Rivaldo Venâncio-da-Cunha; Flavia Barreto Dos Santos
Journal:  Sci Rep       Date:  2019-12-09       Impact factor: 4.379

6.  Enzyme-linked immunosorbent assays using virus-like particles containing mutations of conserved residues on envelope protein can distinguish three flavivirus infections.

Authors:  Wen-Yang Tsai; Kaitlin Driesse; Jih-Jin Tsai; Szu-Chia Hsieh; Robert Sznajder Granat; Olivia Jenkins; Gwong-Jen Chang; Wei-Kung Wang
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

7.  Identification of Anti-Premembrane Antibody as a Serocomplex-Specific Marker To Discriminate Zika, Dengue, and West Nile Virus Infections.

Authors:  Szu-Chia Hsieh; Wen-Yang Tsai; Jih-Jin Tsai; Mars Stone; Graham Simmons; Michael P Busch; Marion Lanteri; Susan L Stramer; Angel Balmaseda; Eva Harris; Wei-Kung Wang
Journal:  J Virol       Date:  2021-09-09       Impact factor: 5.103

8.  Incidence of Zika Virus Infection from a Dengue Epidemiological Study of Children in Ratchaburi Province, Thailand.

Authors:  Pimolpachr Sriburin; Pichamon Sittikul; Nathamon Kosoltanapiwat; Salin Sirinam; Watcharee Arunsodsai; Chukiat Sirivichayakul; Kriengsak Limkittikul; Supawat Chatchen
Journal:  Viruses       Date:  2021-09-10       Impact factor: 5.048

9.  Seroprevalence of Zika Virus in Amphawa District, Thailand, after the 2016 Pandemic.

Authors:  Salin Sirinam; Supawat Chatchen; Watcharee Arunsodsai; Suriya Guharat; Kriengsak Limkittikul
Journal:  Viruses       Date:  2022-02-25       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.